Subscribe
Logo small
Search
banner
Counsel Katarzyna Czyzewska

DNUR 2.0: in anticipation of the next amendment to the drug reimbursement law

MedExpress Team

Katarzyna Czyżewska

Published Sept. 17, 2024 14:46

DNUR 2.0: in anticipation of the next amendment to the drug reimbursement law - Header image
Fot. Marcin Petruszka
The SNUR, or the announced rapid amendment to the Reimbursement Law, is not as quick as expected, however; for a finished draft of the law, whose primary purpose is to correct errors and remove the negative effects of last year's major amendment to the Law on Reimbursement of Medicines, Foodstuffs for Special Dietary Purposes and Medical Devices, has still not been published and submitted for consultation. Rumors are circulating that more details of the draft amendment are expected to be released next week; but we still don't know whether it will already be an amendment bill or just a preview.

Nevertheless, we already know the assumptions of the future draft amendment to the Reimbursement Act, which were presented by the Department of Drug Policy and Pharmacy at the Ministry of Health at a meeting with representatives of applicants held on July 15 this year. From the information presented at the time, it appears that another major amendment to the Reimbursement Law is being prepared, and therefore another DNUR. Among the issues to be covered by the amendments to the legislation were listed:

- reimbursement of drugs for rare diseases - the Health Ministry has announced a change in its approach to reimbursement of such products, including the introduction of multi-criteria analysis as an additional criterion for evaluating reimbursement applications for these drugs;

- Withdrawal of the possibility introduced by DNUR to include selected OTC drugs in reimbursement; instead of reimbursing OTC drugs, the Health Ministry proposes a new procedure for reimbursement applications - at the call of the Health Minister;

- changing the rules regarding the mandatory reduction in the price of a reimbursed drug after the expiration of market exclusivity - the Health Minis...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also

K-Bukiel-2015---Kopia-mala2
Krzysztof Bukiel

Klawo as hell - author's current commentary

Dec. 7, 2022
Walenty-Zajdel_zdjecie
Dec. 30, 2022
Michal-Modro-3
April 3, 2023
Michal-Modro-3
Oct. 11, 2023
Msolecka
Feature Małgorzata Solecka

National vaccination hunt

Dec. 18, 2023